McIlrath & Eck’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $257K | Sell |
3,584
-185
| -5% | -$14.3K | 0.02% | 211 |
|
|
2025
Q4 | $299K | Buy |
3,769
+189
| +5% | +$14.9K | 0.03% | 117 |
|
|
2025
Q3 | $270K | Buy |
3,580
+197
| +6% | +$13.5K | 0.03% | 118 |
|
|
2025
Q2 | $233K | Buy |
3,383
+2,736
| +423% | +$179K | 0.03% | 124 |
|
|
2025
Q1 | $43.9K | Sell |
647
-60
| -8% | -$3.59K | 0.01% | 342 |
|
|
2024
Q4 | $31.8K | Buy |
707
+174
| +33% | +$9.76K | ﹤0.01% | 400 |
|
|
2024
Q3 | $33.5K | Sell |
533
-675
| -56% | -$39.4K | ﹤0.01% | 380 |
|
|
2024
Q2 | $71.4K | Hold |
1,208
| – | – | 0.01% | 229 |
|
|
2024
Q1 | $96.4K | Buy |
1,208
+164
| +16% | +$12.5K | 0.02% | 179 |
|
|
2023
Q4 | $82.4K | Buy |
1,044
+48
| +5% | +$3.42K | 0.01% | 192 |
|
|
2023
Q3 | $69.5K | Sell |
996
-20
| -2% | -$1.42K | 0.01% | 211 |
|
|
2023
Q2 | $70.2K | Sell |
1,016
-12
| -1% | -$854 | 0.01% | 208 |
|
|
2023
Q1 | $76.4K | Buy |
1,028
+12
| +1% | +$1.01K | 0.02% | 191 |
|
|
2022
Q4 | $94.7K | Sell |
1,016
-145
| -12% | -$14K | 0.02% | 157 |
|
|
2022
Q3 | $111K | Buy |
1,161
+220
| +23% | +$21.8K | 0.03% | 134 |
|
|
2022
Q2 | $87K | Sell |
941
-136
| -13% | -$13.3K | 0.03% | 150 |
|
|
2022
Q1 | $109K | Buy |
1,077
+75
| +7% | +$7.88K | 0.03% | 128 |
|
|
2021
Q4 | $103K | Sell |
1,002
-170
| -15% | -$15.7K | 0.03% | 135 |
|
|
2021
Q3 | $99K | Buy |
1,172
+170
| +17% | +$14.2K | 0.03% | 130 |
|
|
2021
Q2 | $84K | Sell |
1,002
-1,665
| -62% | -$136K | 0.03% | 177 |
|
|
2021
Q1 | $201K | Buy |
2,667
+831
| +45% | +$60.5K | 0.07% | 72 |
|
|
2020
Q4 | $125K | Buy |
1,836
+851
| +86% | +$55.4K | 0.05% | 82 |
|
|
2020
Q3 | $58K | Buy |
985
+686
| +229% | +$42.7K | 0.02% | 137 |
|
|
2020
Q2 | $19K | Buy |
299
+57
| +24% | +$3.59K | 0.01% | 245 |
|
|
2020
Q1 | $14K | Buy |
242
+26
| +12% | +$1.74K | 0.01% | 252 |
|
|
2019
Q4 | $16K | Sell |
216
-100
| -32% | -$7.02K | 0.01% | 271 |
|
|
2019
Q3 | $20K | Hold |
316
| – | – | 0.01% | 208 |
|
|
2019
Q2 | $17K | Hold |
316
| – | – | 0.01% | 220 |
|
|
2019
Q1 | $17K | Buy |
316
+3
| +1% | +$185 | 0.01% | 220 |
|
|
2018
Q4 | $21K | Buy |
313
+100
| +47% | +$7.46K | 0.01% | 182 |
|
|
2018
Q3 | $17K | Sell |
213
-50
| -19% | -$3.58K | 0.01% | 226 |
|
|
2018
Q2 | $17K | Buy |
263
+64
| +32% | +$4.22K | 0.01% | 225 |
|
|
2018
Q1 | $12K | Buy |
199
+6
| +3% | +$430 | 0.01% | 235 |
|
|
2017
Q4 | $14K | Buy |
+193
| New | +$14K | 0.01% | 237 |
|
Other funds holding CVS
VCM
VPM
McIlrath & Eck's CVS Position: Q1 2026 in Review
McIlrath & Eck reduced its CVS Health (CVS) stake by 4.9% in Q1 2026, selling an estimated $14.3K and leaving 3,584 shares worth $257K. The position accounts for 0.02% of the portfolio, ranked #211.
McIlrath & Eck first reported a position in CVS in Q4 2017 and has held it in 34 quarters since. The position peaked at $299K in Q4 2025. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- McIlrath & Eck held 3,584 shares of CVS Health worth $257K as of Q1 2026.
- McIlrath & Eck sold 185 CVS Health shares in Q1 2026, an estimated $14.3K.
- CVS Health made up 0.02% of McIlrath & Eck's portfolio in Q1 2026, its #211 holding.
- McIlrath & Eck first reported a position in CVS Health in Q4 2017 and has held it in 34 quarters since.
- McIlrath & Eck's CVS Health position peaked at $299K in Q4 2025.
- 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on McIlrath & Eck's 13F filing for Q1 2026, filed 19 May 2026.